FNY Investment Advisers’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-70
| Closed | -$9K | – | 875 |
|
|
2025
Q1 | $9K | Buy |
+70
| New | +$9K | 0.01% | 487 |
|
|
2023
Q2 | – | Sell |
-204
| Closed | -$56K | – | 502 |
|
|
2023
Q1 | $56K | Buy |
204
+104
| +104% | +$28.5K | 0.06% | 163 |
|
|
2022
Q4 | $27K | Buy |
100
+6
| +6% | +$1.62K | 0.04% | 225 |
|
|
2022
Q3 | $25K | Buy |
94
+79
| +527% | +$21K | 0.02% | 286 |
|
|
2022
Q2 | $3K | Hold |
15
| – | – | ﹤0.01% | 501 |
|
|
2022
Q1 | $3K | Sell |
15
-2,485
| -99% | -$497K | ﹤0.01% | 536 |
|
|
2021
Q4 | $599K | Buy |
+2,500
| New | +$599K | 0.32% | 69 |
|
|
2021
Q1 | – | Sell |
-5,000
| Closed | -$1.22M | – | 736 |
|
|
2020
Q4 | $1.22M | Buy |
+5,000
| New | +$1.22M | 0.33% | 77 |
|
|
2019
Q4 | – | Sell |
-13
| Closed | -$3K | – | 749 |
|
|
2019
Q3 | $3K | Sell |
13
-75
| -85% | -$17.3K | ﹤0.01% | 640 |
|
|
2019
Q2 | $20K | Buy |
+88
| New | +$20K | 0.01% | 462 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 646 |
|
|
2018
Q4 | – | Sell |
-28
| Closed | -$9K | – | 613 |
|
|
2018
Q3 | $9K | Sell |
28
-314
| -92% | -$101K | ﹤0.01% | 494 |
|
|
2018
Q2 | $99K | Buy |
+342
| New | +$99K | 0.04% | 220 |
|